Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, inevitable infectious diseases crisis rears its ugly head."

FluMist Home is an influenza vaccine that’s administered via nasal spray, which means no needles and no waiting in line at the pharmacy. Plus, it’s covered by insurance and experts say it’s about as effective as the traditional flu vaccine. But there’s a catch: It’s only been approved for people ages 2 to 49.

Researchers found that the vaccine, named ELI-002 2P, could trigger lasting immune responses and may help prevent or delay cancer recurrence in high-risk patients whose tumors are driven by KRAS mutations, which are responsible for half of colorectal cancers and more than 90 percent of pancreatic cancers, researchers noted.

Conflicts of interest on the U.S. Centers for Disease Control and Prevention’s vaccine advisory committee were at historic lows around the time when Health Secretary Robert F. Kennedy Jr. fired all 17 members in June,

Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at pharmaceutical giants Eli Lilly and Pfizer that anti-vaccine activist Robert F.

FluMist is the only nasal spray flu vaccine in the U.S. that is FDA approved for at home use. It can be self-administered by adults under 50 and given to children as young as 2.

Australian biotech CSL, the country's fourth-largest company, said on Tuesday it would spin off its vaccine division and shed about 3,000 employees as it reels from "unprecedented volatility," sending its shares tumbling.

CHARLESTON — The West Virginia Board of Education took the next step to appeal a lower court ruling that kept in place a religious exemption to the state’s compulsory immunization law for the children of three Raleigh County parents.

CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine subsidiary in a wide-ranging restructure.

Conflicts of interest on government vaccine panels were at historic lows before RFK Jr.'s overhaul, while Epic touts new AI tools at annual Users Group Meeting.